Orphan Drugs and Rare Diseases

Alastair Kent

Published by Royal Society of Chemistry, 2014
ISBN 10: 1849738068 / ISBN 13: 9781849738064
Used / HRD / Quantity Available: 0
Available From More Booksellers
View all  copies of this book

About the Book

We're sorry; this specific copy is no longer available. AbeBooks has millions of books. We've listed similar copies below.

Description:

New Book.Shipped from US within 10 to 14 business days. Established seller since 2000. Bookseller Inventory #

About this title:

Book ratings provided by Goodreads:
0 avg rating
(0 ratings)

Synopsis:

Orphan drugs are designated drug substances that are intended to treat rare or ‘orphan’ diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world’s population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target.


Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research.


Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat.


Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia.

Book Description: Orphan drugs are designated drug substances that are intended to treat rare or ‘orphan’ diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world’s population, but individually, any single rare disease may only affect a handful of people making them unattractive for the biopharmaceutical industry to target. Providing an up-to-date mongraph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs.

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Orphan Drugs and Rare Diseases
Publisher: Royal Society of Chemistry
Publication Date: 2014
Binding: HRD
Book Condition: New

Top Search Results from the AbeBooks Marketplace

1.

ISBN 10: 1849738068 ISBN 13: 9781849738064
New Quantity Available: 1
Seller:
BWB
(Valley Stream, NY, U.S.A.)
Rating
[?]

Book Description Book Condition: New. Depending on your location, this item may ship from the US or UK. Bookseller Inventory # 97818497380640000000

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 187.14
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

2.

Alastair Kent, David C. Pryde, Michael Palmer, David Fox, Alan Kimura
Published by Royal Society of Chemistry
ISBN 10: 1849738068 ISBN 13: 9781849738064
New Hardcover Quantity Available: 1
Seller:
THE SAINT BOOKSTORE
(Southport, United Kingdom)
Rating
[?]

Book Description Royal Society of Chemistry. Hardback. Book Condition: new. BRAND NEW, Orphan Drugs and Rare Diseases, Alastair Kent, David C. Pryde, Michael Palmer, David Fox, Alan Kimura, Orphan drugs are designated drug substances that are intended to treat rare or 'orphan' diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world's population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target. Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research. Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat. Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia. Bookseller Inventory # B9781849738064

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 214.90
Convert Currency

Add to Basket

Shipping: US$ 9.37
From United Kingdom to U.S.A.
Destination, Rates & Speeds

3.

Published by Royal Society Of Chemistry, United Kingdom (2014)
ISBN 10: 1849738068 ISBN 13: 9781849738064
New Hardcover Quantity Available: 10
Seller:
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description Royal Society Of Chemistry, United Kingdom, 2014. Hardback. Book Condition: New. Language: English . Brand New Book. Orphan drugs are designated drug substances that are intended to treat rare or orphan diseases. More than 7000 rare diseases are known that collectively affect some 6-7 of the developed world s population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target. Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research. Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat. Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia. Bookseller Inventory # AAJ9781849738064

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 232.04
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

4.

Published by Royal Society Of Chemistry, United Kingdom (2014)
ISBN 10: 1849738068 ISBN 13: 9781849738064
New Hardcover Quantity Available: 10
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Royal Society Of Chemistry, United Kingdom, 2014. Hardback. Book Condition: New. Language: English . Brand New Book. Orphan drugs are designated drug substances that are intended to treat rare or orphan diseases. More than 7000 rare diseases are known that collectively affect some 6-7 of the developed world s population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target. Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research. Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat. Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia. Bookseller Inventory # AAJ9781849738064

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 235.58
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Alastair Kent
Published by Royal Society of Chemistry (2014)
ISBN 10: 1849738068 ISBN 13: 9781849738064
New Quantity Available: > 20
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Royal Society of Chemistry, 2014. HRD. Book Condition: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Bookseller Inventory # CA-9781849738064

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 234.76
Convert Currency

Add to Basket

Shipping: US$ 12.15
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Pryde,Palmer
Published by Royal Society of Chemistry 2014-08-15 (2014)
ISBN 10: 1849738068 ISBN 13: 9781849738064
New Quantity Available: 5
Seller:
Chiron Media
(Wallingford, United Kingdom)
Rating
[?]

Book Description Royal Society of Chemistry 2014-08-15, 2014. Book Condition: New. Brand new book, sourced directly from publisher. Dispatch time is 24-48 hours from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Bookseller Inventory # NU-MAR-00050243

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 238.33
Convert Currency

Add to Basket

Shipping: US$ 4.03
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

ISBN 10: 1849738068 ISBN 13: 9781849738064
New Quantity Available: 3
Seller:
Majestic Books
(London, ,, United Kingdom)
Rating
[?]

Book Description Book Condition: New. Bookseller Inventory # 142535925

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 249.77
Convert Currency

Add to Basket

Shipping: US$ 7.42
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

Published by Royal Society of Chemistry (2014)
ISBN 10: 1849738068 ISBN 13: 9781849738064
New Hardcover Quantity Available: 2
Seller:
Murray Media
(North Miami Beach, FL, U.S.A.)
Rating
[?]

Book Description Royal Society of Chemistry, 2014. Hardcover. Book Condition: New. Never used!. Bookseller Inventory # P111849738068

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 268.47
Convert Currency

Add to Basket

Shipping: US$ 1.99
Within U.S.A.
Destination, Rates & Speeds

9.

Published by Royal Society of Chemistry (2014)
ISBN 10: 1849738068 ISBN 13: 9781849738064
Used Hardcover Quantity Available: 2
Seller:
Murray Media
(North Miami Beach, FL, U.S.A.)
Rating
[?]

Book Description Royal Society of Chemistry, 2014. Hardcover. Book Condition: Very Good. Great condition with minimal wear, aging, or shelf wear. Bookseller Inventory # P021849738068

More Information About This Seller | Ask Bookseller a Question

Buy Used
US$ 268.48
Convert Currency

Add to Basket

Shipping: US$ 1.99
Within U.S.A.
Destination, Rates & Speeds

10.

Published by Royal Society of Chemistry (2014)
ISBN 10: 1849738068 ISBN 13: 9781849738064
New Hardcover First Edition Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Royal Society of Chemistry, 2014. Hardcover. Book Condition: New. book. Bookseller Inventory # M1849738068

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 282.63
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

There are 5 more copies of this book

View all search results for this book